A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza

Summary

The purpose of this study is to evaluate how well CD388 works in preventing symptomatic laboratory-confirmed influenza infections, as compared to placebo, when given as a single dose via 3 subcutaneous (SQ) injections to adult and adolescent participants who are at higher risk of developing influenza complications, and to evaluate the safety and tolerability of CD388, as compared to placebo.

Timeline

Start

2025-09-25

Primary completion

2027-06

Completion

2027-06

Drugs

Indications